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Abstract 
Previous studies have shown that mild cognitive impairment (MCI) may be reflective of the early 
stages of more pronounced neurodegenerative disorders such as Alzheimer’s disease (AD). There is a 
need for a minimally invasive and inexpensive diagnostic to identify those who exhibit cellular 
pathology indicative of MCI and AD risk so that they can be prioritised for primary preventative 
measures. The hypothesis was that a minimally invasive approach using cytological markers in 
isolated buccal mucosa cells can be used to identify individuals of both MCI and AD. An automated 
buccal cell assay was developed using laser scanning cytometry (LSC) to measure buccal cell type 
ratios, nuclear DNA content and shape, and neutral lipid content of buccal cells from clinically 
diagnosed AD (n=13) and MCI (n=13) patients prior to treatment compared to age- and gender-
matched controls (n=26). DNA content was significantly higher in all cell types in both MCI (P<0.01) 
and AD (P<0.05) compared with controls mainly due to an increase in >2N nuclei. Abnormal nuclear 
shape (circularity) was significantly increased in transitional cells in MCI (P<0.001) and AD (P<0.01) 
when compared to controls. In contrast, neutral lipid content (as measured by Oil red O “ORO” 
staining) of buccal cells was significantly lower in the MCI group (P<0.05) compared with the control 
group. The ratio of DNA content/ORO in buccal basal cells for both MCI and AD was significantly 
higher compared to the control group, with ratios for MCI being approximately 2.8-fold greater 
(P<0.01) and AD approximately 2.3-fold greater (P<0.05) than the control group. Furthermore, there 
was a strong negative correlation between buccal cell DNA content and ORO content in the AD 
group (r2=0.75, P<0.0001) but not in MCI or controls. The changes in the buccal cell cytome observed 
in this study could prove useful as potential biomarkers in identifying individuals with an increased 
risk of developing MCI and eventually AD.  
 
 
Keywords: Cell imaging, biomarkers, oral epithelium, Alzheimer’s disease, cognitive impairment, 
laser scanning cytometry, neutral lipids, hyperdiploidy. 
  François et al. 
Page | 3  
 
Introduction 
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised clinically by a gradual and 
progressive loss of memory, cognitive decline, behavioural changes and is the most common cause 
of dementia (1,2). In clinical practice, patients with AD are not usually identified until the disease has 
progressed to an advanced stage of cognitive impairment. Neurodegenerative diseases such as 
Alzheimer’s and Parkinson’s disease have a predicted increased incidence of 300% in the next thirty 
years due to an ever ageing population, especially in developing countries (3). This has become a 
global concern and threatens to impact heavily both socially and economically (4-6). A minimally 
invasive approach to identify individuals at increased risk for AD before the disease process becomes 
irreversible and to enhance the possibility of success of preventative diet and life-style strategies 
would be highly desirable. 
One of the minimally invasive strategies is to use biomarkers in the cells of the buccal 
mucosa collected by the gentle brushing of the inside of the cheeks. Since the buccal mucosa is of 
ectodermal origin, defects in these cells may reflect potential changes in the pathology of other 
tissues of ectodermal origin such as the central nervous system. Biomarkers that may identify 
individuals earlier in life who are at an increased risk of developing mild cognitive impairment (MCI) 
and AD would be useful as this would allow timely preventative intervention. In a recent pilot study 
by our group the validation of the full spectrum of biomarkers scoreable in the buccal micronucleus 
cytome assay was determined using a cytological classification of buccal mucosa cells (7-9).  These 
studies showed that individuals who had just been clinically diagnosed with AD and prior to any 
medication have a significantly different buccal cytome profile compared to unaffected age- and 
gender-matched controls. In particular, there was a significant reduction in both basal and 
karyorrhectic buccal cell frequency which are associated with regenerative potential and cell death, 
respectively. The odds ratio for diagnosing individuals with AD having a combined basal and 
karyorrhectic frequency of <41/1000 cells is 140 with a specificity of 97% and a sensitivity of 82% (8), 
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representing a potential biomarker for AD risk. These differences relative to controls were also 
evident in Down’s syndrome, which is a syndrome of accelerated aging and high propensity for 
development of AD (10). Both conditions were also associated with elevated DNA damage as 
measured by an increase in the buccal cell micronucleus frequency, which is a biomarker of whole 
chromosome loss and/or breakage, and increases in chromosome 17 and chromosome 21 
aneuploidy (11). Furthermore, abnormal DNA content (e.g. hyperdiploidy in nuclei) is a marker of 
DNA damage resulting from chromosome mis-segregation and has been demonstrated to occur in 
the aging human brain (12) and in the brain of AD patients (13), but to our knowledge has not been 
previously determined in a quantitative and automated manner in human buccal mucosa cells. 
There have been several studies demonstrating that a variety of lipid classes are 
substantially altered at a very early stage during AD pathogenesis (14,15). Furthermore, relative to 
controls, altered levels of plasma apoE in AD have been observed (16,17). Previous studies in both 
animal and cellular AD models indicated that intracellular cholesterol distribution can regulate β-
amyloid (considered the main biomarker of AD) generation in the brain (18). A recent study showed 
that skin fibroblasts from patients with a diagnosis of probable sporadic AD display an imbalance 
between free cholesterol and cholesterol ester pools (19). Furthermore, Oil Red-O staining 
(indicative of accumulation of neutral lipids) was used to demonstrate higher levels of neutral lipids 
in isolated peripheral blood mononuclear cells of probable AD patients (20). Since there is a lack of 
data available on accumulation of neutral lipids within buccal cells in vivo, this parameter was also 
investigated in healthy controls and individuals diagnosed with MCI and AD. 
The aim of this study was to develop and validate the use of an automated high-content Laser 
scanning cytometry (LSC) protocol (21) to assess whether buccal cell cytoplasm, nuclear and lipid 
parameters could be used for identifying those at increased risk of developing AD. Since LSC has 
previously been used successfully to analyse intracellular markers of single cells within 
subpopulation of neurons (22,23), an automated LSC cytome approach was developed in our study 
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to analyse single cells from various cell types in the buccal mucosa. Their DNA content and neutral 
lipid content and their ratios were quantified to identify which parameters, if any, were most 
strongly associated with those subjects who were diagnosed with MCI or classified as AD. The results 
of this study show that LSC analysis of buccal cells can yield important diagnostics for identifying 
those individuals with MCI and AD. 
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Materials and Methods 
Human ethics 
Approval for this study was obtained from CSIRO, University of Adelaide and Ramsay Healthcare 
Ethics Committees. Mild cognitively impaired and Alzheimer’s patients were recruited at College 
Grove Private Hospital, Walkerville, Adelaide, South Australia, following their initial diagnosis and 
prior to commencement of therapy. Diagnosis of both MCI and AD was made by clinicians (Dr. Jane 
Hecker and Dr. Jeffrey Faunt) according to the criteria outlined by the National Institute of 
Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and related Disorders 
Association (NINCDS–AD&DA) (24), which are the well recognized standards used in all clinical trials. 
Inclusion criteria were as follows: (1) Mild cognitively impaired (MCI) group (n=13): male (n=2) or 
female (n=11), clinically diagnosed with MCI. (2) AD group (n=13): male (n=2) or female (n=11), 
clinically diagnosed with AD. (3) Control Group (n=26): male (n=4) or female (n=22) healthy controls 
not clinically diagnosed with MCI or AD. Exclusion criteria for all groups were as follows; patients 
who were undergoing chemotherapy/radiotherapy treatment for cancer, patients supplementing 
with micronutrients associated with genome maintenance (e.g. folate, vitamin B12) above 
recommended dietary intakes. 
 
Chemicals and Reagents 
NaCl, Tris(hydroxymethyl)aminomethanehydrochloride (Tris), ethylenediaminetetraacetic acid 
(EDTA), sodium citrate, 4',6-diamidino-2-phenylindole  (DAPI), formaldehyde, glycerol, 1-[2,5-
Dimethyl-4-(2,5-dimethylphenylazo)phenylazo]-2-naphthol (Oil Red O),  triethyl-phosphate and fast 
green were from Sigma-Aldrich (Castle Hill, NSW, Australia). Phosphate buffered saline (PBS) was 
from Invitrogen (Mulgrave, Victoria, Australia). All chemicals were of the highest quality grade. 
 
Buccal cell isolation 
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Consented participants had a one-off buccal cell sample collected after a brief information session 
outlining the purpose of the study. Buccal cells were collected from the study participants by a 
trained nurse as described previously (9) to prevent any potential bias introduced by having multiple 
samplers. Cell concentration was measured using a hemocytometer and cells transferred by 
cytocentrifugation to a microscope slide using a Shandon Cytospin 4 (600 rpm) at a concentration of 
60,000 cells/mL to obtain a final cell density of approximately 3,000 cells per cytospot in duplicate. 
Slides were then air-dried for 15 min and subsequently transferred to 0.4% formaldehyde in PBS for 
10 min, rinsed for 1 min with ultra pure water generated from a Milli-Q water purification system 
(Millipore Australia Pty Ltd, NSW, Australia) and air dried for 1 hr, then stored in sealed microscope 
boxes with desiccant at -20°C until the staining procedure was performed. 
 
Staining procedures 
Microscope slides containing buccal cells were defrosted by allowing them to warm to room 
temperature and then stained in randomized batches of 8 including a positive-stained control slide. 
Positive control slides were prepared with buccal cells from a single person to ensure that the 
staining procedure was the same for each batch. Microscope slides were washed 3 times for 30 sec 
each in 1% triethyl-phosphate in ultra pure water and then incubated with Oil Red O (ORO) staining 
working solution (3 mg/mL ORO in 36% triethyl-phosphate) for 45 min in the dark, to stain for 
neutral lipids. Slides were then washed 3 times with 1% triethyl-phosphate to remove excess ORO 
and nuclei stained with DAPI (0.2 μg/mL) for 5 min. The excess DAPI was removed by rinsing the 
slides in 300 mM NaCl, 34 mM sodium citrate and then slides were further stained in 0.2% (w/v) fast 
green for 30 min in the dark, to stain cytoplasm. The excess fast green was removed by rinsing the 
slides for 1 minute with running tap water. Slides were then mounted with coverslips and 
PBS:Glycerol (1:1) medium. To avoid drying, the coverslips were sealed around the edge with nail 
polish and kept in a box in the dark at -20°C for up to three days until analysed by LSC. 
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Laser scanning cytometry measurement of nuclear DNA content, nuclear circularity, neutral lipids 
and cell sub-types. 
Microscope slides were inserted into a 4 slide carrier and analysed by iCyte® Automated Imaging 
Cytometer (CompuCyte Corporation, Westwood, MA, USA). Lasers selected for the high-content 
assays were 405 nm, 488 nm and 633 nm to detect DAPI, ORO and Fast Green, respectively. The blue 
photomultiplier tube (PMT) was used to collect fluorescence from DAPI while the Long Red PMT was 
utilised to capture fluorescence from Fast Green. As ORO is a chromatic stain, the 488 photo 
detector was set to quantify its absorbance. 
Buccal cells were not always completely dissociated into single isolated cells, but rather, it 
was noted they exist as populations of single cells and groups of cells. To identify the individual cell 
types within the population of buccal cells (the buccal cytome) using LSC it was necessary to apply 
mechanical dissociation procedures (homogenising, passing the cell suspension through a small 
orifice e.g. 21-gauge needle and a porous Millipore membrane) to the isolated buccal cell samples. 
Nevertheless, following this stringent protocol, some cells remained in small clusters of 2-6 cells on 
the microscope slides. Therefore our initial aim was to analyse all cells on the microscope slides, 
regardless of whether the cells were isolated single cells or those that were in small groups of 2-6 
cells that were not completely dissociated during the mechanical separation procedures. 
Additionally, using the iCyte software we were able to analyse the isolated single cells in more detail 
by LSC and classify these cell types (as basal, transitional, differentiated and karyolytic) based on 
cytoplasm area and several nuclear staining parameters and features such as circularity (a measure 
of abnormal shape), integral (a measure of DNA content based on integrated optical density of pixels 
within a defined contoured area) and area. Figure 1 shows the different ways of analysing buccal 
cells with LSC. Cells belonging to a group of cells could not be contoured separately but their nuclei 
and oil droplets were successfully contoured and could be analysed to provide cytoplasm, lipid and 
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nuclear data for all cell types combined. For classification and scoring of separated single cell types 
using the buccal cytome approach, a further categorisation was performed which then identified 
cells as having 0 or 1 nuclei. Cells without nuclei were classified as karyolytic, and single cells were 
segregated from large clumps by excluding all cells with more than one nucleus scored, 
unfortunately excluding at the same time binucleated buccal cells. Binucleated buccal cells could not 
be separated from the analysis as it was not possible to properly distinguish them from clumps 
composed of two buccal cells. However we have also noted previously that true binucleated buccal 
cells are relatively rare events occurring less than 1% of all scored cells (9). Mononucleated cells 
which were subsequently scored in the automated buccal cytome assay (i.e. single cells) were 
further categorised into 3 new regions based on the cytoplasm area as well as the 
NuclearArea/CytoplasmArea ratios. Following this procedure, buccal cells were categorized as basal, 
transitional or differentiated cells. To verify that this categorization of cells was similar to that used 
in our previous (non-automated) study (8-10), galleries of cells were viewed to allow the proper 
categorization based on the cytoplasm area as well as the NuclearArea/CytoplasmArea ratios. For each 
participant 500 cells on average were scored to determine the frequency of each cell type in the 
buccal cytome depending on the slide preparation. 
Prior to each batch scan, the same control slide containing previously stained buccal cells 
sampled from a single person was scanned to ensure all settings and measurements made by LSC 
had not drifted from the actual original standard values. There was no detectable drift over the 
course of the study. The fluorescence (and absorbance where appropriate) of events were recorded 
as follows: area, count (number of events), circularity, and fluorescence integral or inverted 
absorbance. DNA content and neutral lipid content was assessed in two ways. Firstly the entire 
cytospot was considered as a tissue section, and all nuclei were examined to obtain nuclear content 
data (a minimum of 500 and a maximum of 2000 nuclei were analysed per participant depending on 
the slide preparation); the relative DNA content of the nuclei was determined by the integral of DAPI 
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fluorescence values. Neutral lipid content was determined from the ratio of ORO area/Fast Green 
(cytoplasm) area in 500 single cells per participant. Single cells on the microscope slide (as in Figure 
1B, C, D and E) were classified in a similar manner to previously, using the buccal cytome approach 
(8-10). This allowed us to score the cell population consisting of basal, transitional, and 
differentiated or karyolytic cell types by adapting an automated scoring system that was developed 
using the iCyte software (21). Thus, it was then possible to investigate DNA content and neutral 
lipids in more detail within the defined cell populations. 
 
Statistics 
One-way analysis of variance (ANOVA) and linear correlation analyses were carried out to determine 
the significance of the cellular parameters measured between the control, MCI and AD groups. 
Pairwise comparison of significance between these groups was determined using Tukey-Kramer test 
as all pairs of columns of unequal sample sizes were compared. ANOVA and correlation values were 
calculated using GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA). Significance was 
accepted at p<0.05. Receiver-operating characteristic curves (ROC) were carried out for selected 
parameters between the control and MCI groups to obtain area under the curve (AUC), confidence 
interval, P-value, sensitivity and specificity scores. When tested with the Fisher’s exact test, no 
significant differences were observed in the gender-ratio between groups. 
 
  François et al. 
Page | 11  
 
Results 
The mean ± SEM of the age and the mini–mental state examination (MMSE) scores for each of the 
groups are as follows: control group (76.1 ± 1.5 / 28.4 ± 0.3), MCI (75.3 ± 1.8 / 26.3 ± 0.5) and AD 
(77.7 ± 2.8 / 21.2 ± 1.1). No significant differences were observed for the age of participants 
between groups, however there was a significant decrease in the MMSE score of the AD group 
compared with the control group (p<0.05). 
 
Buccal cytome 
Using the protocol as described in the methods section single cells were scored based on several 
cytoplasmic and nuclear staining parameters. Nuclei and cytoplasm size are indicated as the mean ± 
SEM. We identified and classified the buccal cytome with the following cell types; basal (Figure 1B), 
transitional (Figure 1C), differentiated (Figure 1D) and karyolytic cells (Figure 1E). Basal cells are the 
cells from the basal layer which are smaller in size (1200 μm2 ± 285)  when compared to terminally 
differentiated buccal cells (3900 μm2 ± 930)  and have a nuclear to cytoplasm ratio (0.064 a.u. ± 0.02) 
that is larger than in differentiated buccal cells (0.018 a.u. ± 0.007). According to our LSC 
classification criteria, basal cell frequency was 12.7%, 15% and 15.4% for control, MCI and AD, 
respectively. Transitional cells were classified as a group of cells that were neither large fully 
differentiated cells nor small basal cells. Transitional cells showed a larger cytoplasm (2150 μm2 ± 
455) and smaller nuclear to cytoplasm ratio (0.031 a.u. ± 0.001) than basal cells with a frequency of 
34.5%, 27.1% and 29.5% for control, MCI and AD, respectively. Differentiated cells were 
distinguished from basal cells and transitional cells by having the largest cell size (3900 μm2 ± 930) 
and smallest nuclear to cytoplasmic ratio (0.018 a.u. ± 0.007); (Figure 3C) with a frequency of 27% 
for control, 29% for MCI and 30.4% for the AD group. Karyolytic cells were another group of cells 
scored that were characterised by having nuclei completely depleted of DNA and therefore showed 
no DAPI staining. These cells likely represent a very late stage in the cell death process. There was no 
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significant difference in the karyolytic, basal, transitional or differentiated buccal cell frequency 
between the 3 groups. 
 
DNA content 
Nuclear DNA content of all buccal cells on the microscope slides within the cytospots was 
determined by measuring the DNA integral of all nuclei. Figure 2A shows that there was a 
significantly higher nuclear DNA content in buccal cells from the MCI group (p<0.01) and AD groups 
(p<0.05) compared with the control group when all cells were analysed but there was no significant 
difference between the MCI and AD groups. Furthermore, when only the single mononucleated cells 
were analysed, DNA content values were also increased in nuclei for MCI (p<0.01) and AD (p<0.05) 
compared to controls, as shown in Figure 2B. Therefore, the values obtained from the single 
separated cell analyses were comparable to those obtained from all cells including those in small 
clumps. As a next step in the analysis of individual buccal cells by LSC, we investigated the DNA 
content of the different cell types that contained nuclei i.e. basal, transitional and differentiated 
buccal cells. Figure 2C shows the results of nuclear DNA content analyses by LSC in basal cells. Both 
MCI and AD groups had a significantly higher DNA content in basal buccal cells compared with 
controls (p<0.001 and p<0.01, respectively). In transitional cells (Figure 2D) there was a significantly 
higher nuclear DNA content in the MCI (p<0.01) group compared with controls. Similarly, in fully 
differentiated buccal cells there was a significantly higher DNA content in the MCI (p<0.01) group 
compared with controls (Figure 2E). Overall it was evident that DNA content of buccal cells from the 
AD and MCI groups was 55% and 72% greater than for controls, respectively. 
 
Neutral lipids 
LSC was used to simultaneously determine the content of neutral lipids in buccal cells by staining 
cells with ORO. ORO is a lysochrome fat-soluble dye which has been used for demonstrating the 
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presence of neutral lipids such as cholesteryl esters and triglycerides in cells (19,20). Upon staining, 
the neutral lipids appear as bright red spots in the cytoplasm. When all cells were examined 
(including groups of cells), there was a significantly lower (p<0.05) ORO in the MCI group compared 
with the controls and there was no significant difference between controls and AD (Figure 3A). 
Similarly, Figure 3B shows a significant decrease (p<0.05) in ORO between MCI and controls when 
only the single separate buccal cells were analysed. We further investigated ORO content in the 
specific buccal cell types. Figure 3C demonstrates that ORO staining was significantly lower in the 
MCI group compared with the control group in the basal cells (p<0.05), transitional cells (Figure 3D; 
p<0.05) and karyolytic cells (Figure 3F; p<0.01), whilst there was no significant difference in 
differentiated cells (Figure 3E) between MCI, AD and their relative controls. Additionally, there was 
no significant difference between either the control and AD groups or the MCI and AD groups for 
any of the buccal cell types. 
 
DNA/ORO ratio 
Since the DNA content was increased in the MCI and AD groups compared with the control group, 
and ORO content showed a trend to being lower in the AD group and was significantly lower in the 
MCI group compared with the control group, we investigated whether applying a DNA content/ORO 
ratio would amplify the differences observed in the buccal cells. Figure 4A shows the DNA/ORO 
ratios in all buccal cell types examined (single cells and cells in small groups) and interestingly, the 
DNA/ORO ratio was significantly higher (2.8-fold) in the MCI group compared with control group 
(p<0.001), however DNA/ORO ratio was not significantly higher for the AD group compared with the 
control group. To further identify the cell types contributing to this difference in DNA/ORO ratios, we 
analysed the DNA/ORO in the individual separated cells containing nuclei (Figure 4B) and found that 
there was a significantly higher DNA/ORO ratio in MCI (p<0.001) buccal cells compared with control 
buccal cells. On further analysis of the individual cell types, there was a significantly higher DNA/ORO 
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ratio in basal cells for MCI (p<0.01) and AD (p<0.05) compared with control (Figure 4C). Additionally, 
there was a significantly higher DNA/ORO ratio in transitional cells for MCI (p<0.01) compared with 
control (Figure 4D), as well as a significantly higher DNA/ORO ratio in differentiated cells for MCI 
(p<0.01) and AD (p<0.05) compared with control (Figure 4E). 
To further investigate the differences observed, we then explored whether there was a 
correlation between DNA content and ORO content in buccal cells. Interestingly, when all cell types 
(including groups of cells) were examined, there was a significant negative correlation of DNA 
content with ORO content in the AD group (r = -0.86; p<0.0001) and MCI group albeit to a weaker 
extent (r = -0.5, p=0.0093). This strong negative correlation was also apparent in individual 
mononucleated cells (collectively; basal, transitional, differentiated), (r = -0.86, p<0.0001) as well as 
basal (r = -0.65, p<0.001), transitional (r = -0.77, p<0.0001) and differentiated cells (r = -0.70, 
p<0.0001) separately, for AD cases but not for MCI or controls.  
 
Hyperdiploidy 
To investigate if the increase of DNA content observed in MCI and AD was due to either a lower 
proportion of hypodiploid nuclei or a higher proportion of hyperdiploid nuclei compared to controls, 
ploidy was measured by plotting nuclei on a histogram depending on their DAPI Integral. Peaks of 
<2N, 2N and >2N nuclei were then defined and the percentage of nuclei in each of these categories 
was obtained (Figure 5). Representative DNA histograms from each group, control, MCI and AD are 
shown in Figure 5A, 5B and 5C, respectively. It appeared that a shift occurred in nuclei from the 2N 
peak towards the >2N peak in MCI and AD when compared to control. Figure 5D summarises the 
data where percentage of nuclei in the different peaks (<2N, 2N and >2N) for each of the three 
groups are shown. Buccal cells from MCI as well as AD cases exhibited a decrease in the percentage 
of 2N nuclei (p<0.001 and p<0.01, respectively) with a concomitant increase in the percentage of 
>2N nuclei when compared to buccal cells from controls (p<0.01 and p<0.05, respectively). 
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Interestingly, no changes occurred in the <2N nuclei population which indicated that the increase in 
DNA content observed in MCI and AD was not due to a decrease in hypodiploidy but due to an 
increase in hyperdiploidy. We also measured irregular nuclear shape (circularity) relative to the 
normal smooth and circular to oval nuclear perimeter, with a high circularity value indicating a more 
irregular-shaped structure. The results indicated a significantly increased circularity (and thus a more 
irregular shape) of nuclei in transitional cells from MCI and AD cases relative to controls (p<0.001 
and p<0.01 respectively, Figure 5E). Interestingly, when investigated in all cells (including groups of 
cells), circularity was found to be significantly higher in MCI (p<0.05) but not in AD when compared 
to control (data not shown). 
 
ROC curves 
For each of the parameters analysed, receiver-operator characteristic (ROC) curves were generated. 
The area under the curve, confidence interval, P values, specificity and sensitivity scores were 
calculated. Only ROC curves for biomarkers and their combinations that showed differences 
between groups were investigated using the results for all cell types combined (Table 1). These 
results indicate a strong diagnostic value of these biomarkers or their combinations for identifying 
MCI cases relative to controls with AUC values ranging from 0.76 for nuclear DNA content to 0.84 for 
the combination “Circularity + ORO”. 
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Discussion 
The objective of the present study was to develop and test an LSC-based method to measure novel 
additional biomarkers in the buccal micronucleus cytome assay (9) such as simultaneous 
measurement of nuclear DNA content/aneuploidy and neutral lipid content in buccal cells of MCI 
and AD individuals relative to controls. This study demonstrated significant changes in buccal cells 
isolated from MCI and AD subjects including the buccal cell type ratio, increased nuclear DNA 
content, nuclear circularity and DNA content/neutral lipid ratio in both MCI and AD subjects relative 
to controls. 
An advantage of LSC scoring of buccal cells is that all the microscope slides are scanned with 
the same LSC settings (21), i.e. the software is set up in such a manner that all slides are examined 
using identical parameters and the numerical values obtained by the quantitative imaging allows for 
the separation of cell types, thus removing the potential for subjectivity existing from one individual 
scorer to another. Our LSC results did not support previous observations of substantial differences in 
frequency of the cell types between the control and Alzheimer’s group when visual analysis was 
used (8,25), which may be due to the exclusion of cells in clumps in the LSC method and the different 
staining methods used 
To define the cell types present we aimed to classify the cells depending on their 
developmental stage based upon some of the visual scoring criteria developed by our group and the 
HUMNXL project (8). Previously, these criteria when used with a visual scoring suggested that the cell 
composition of the buccal mucosa was significantly altered in Alzheimer’s patients i.e. significant 
reduction in basal cells, karyorrhectic and condensed chromatin cells (the latter two being 
biomarkers of cell death) (8). These changes were possibly explained by a decrease in the 
regenerative potential of the buccal mucosa in AD. The frequency of different cell types obtained in 
our current study using LSC was somewhat different than the previous visual scoring method which 
may partly be explained by the different staining procedures used in these studies, and because 
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karyorrhectic and condensed chromatin cells could not be reliably identified in the LSC method. It 
was assumed that these would appear as cells with nuclei having a <2N DNA content because 
karyorrhectic and condensed chromatin cells are thought to be apoptotic leading to nuclear 
fragmentation. However, there was no evidence that the frequency of <2N nuclei was reduced in 
MCI or AD.  
In this study aneuploidy was measured by quantitating the fluorescent integral of the DAPI 
signal, providing data on nuclear DNA content as shown previously with Feulgen staining (26). 
Results showed a significantly higher DNA content in buccal cells from the MCI group (p<0.01) and 
AD group (p<0.05) compared with the control group. The ploidy distribution of nuclei showed that 
MCI and AD cases presented a decrease in the frequency of 2N nuclei which was accompanied by an 
increase in hyperdiploid nuclei as well as nuclear circularity. Therefore, the higher DNA content 
observed in MCI and AD cases might be partly explained by the accumulation of buccal cells in the S 
and G2 phase of the cell cycle. The observed hyperdiploidy may be due to cell cycle checkpoint 
arrest due to mitotic defect leading to mitotic slippage which can lead to generation of 4N cells (27). 
Another possibility is malsegregation of chromosomes leading to trisomic and monosomic cells 
assuming that the former are more likely to survive. An increase in trisomy 21 and trisomy 17 has 
been reported in buccal cells in AD cases when compared to their respective controls (11). 
Furthermore micronuclei are a biomarker of chromosome malsegregation and tend to be elevated in 
lymphocytes, fibroblasts and buccal cells of AD cases (8,28,29). Other DNA damage markers such as 
γH2AX (DNA double strand breaks) and 8HOdG (oxidative DNA damage) were also found to be linked 
with AD (30-32) and previously detected in human buccal cells (33,34). Therefore, the genomic 
instability events observed previously may partly explain the results of increased DNA content 
observed in this study when measured quantitatively by LSC. 
Changes in lipid composition in the brain have been reported in AD, for example both 
membrane cholesterol and phospholipids were found to be significantly reduced in the cortex of AD 
  François et al. 
Page | 18  
 
mice (35), and the lipid composition of different regions in the human brain have been shown to 
change with ageing as well as in AD (36,37). Our study demonstrates for the first time that ORO 
content decreases in the oral mucosa of MCI in all cell types examined (p<0.05) when compared to 
controls. The ORO content also tended to decrease in AD but this did not reach statistical 
significance. Thus it is possible that changes in neutral lipid accumulation in buccal cells precedes AD 
and is elevated at an early stage of AD pathogenesis. Furthermore, it was noted that the DNA 
content/ORO ratio was significantly elevated compared with controls in both the MCI and AD group 
in all cell types scored. Additionally a strong negative correlation was observed between DNA 
content and ORO in the AD group in all cell types but this type of correlation was not observed in 
controls or to a lesser extent in MCI suggesting a link between hyperdiploidy and lipid content in 
cells as progression from MCI to AD occurs. However we have no obvious explanation for this finding 
unless cell cycle arrest and mitotic slippage is caused by lack of lipid-derived energy required for 
completion of the mitotic process. Alternatively, inadequate stores of lipids may reduce the capacity 
to synthesise sufficient cytoplasmic membrane requirements for mitosis completion leading to 
cytokinetic arrest and aneuploidy (38). Lipid metabolism has also been studied in fibroblasts from AD 
patients whereby the cholesterol esterification rate was reported to increase after 48 hours of 
cellular tissue culture (p<0.05) (19). This level of cholesteryl ester synthesis was linked to an 
expanded cytoplasmic pool of neutral lipid measured using the ORO staining procedure. In a second 
study, Pani et al (20) also investigated the DNA synthesis of lymphocytes after growth-stimulation 
with phytohemagglutinin and found that neutral lipid content increased in parallel with the rate of 
cell growth in vitro, supporting the possibility that the optimal nutrition in culture medium restored 
the capacity of cells to maintain cholesteryl ester synthesis. We previously hypothesised that the 
regenerative potential of the buccal mucosa was reduced with development of AD (8,10), and 
therefore it is possible that the rate of regeneration and proliferation of buccal cells influences the 
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cytoplasmic accumulation of neutral lipids in vivo; this may partly explain why a decrease of neutral 
lipid content in buccal cells occurs in the early stage of AD.  
To-date there has been no simple, inexpensive and minimally invasive procedure available to 
confirm the early diagnosis of AD. Therefore, if screening of populations of individuals is to be 
performed, more suitable, easily accessible tissues would need to be used, also using diagnostic 
tests at much lower costs compared to brain imaging and cerebrospinal fluid diagnostics of amyloid 
β and Tau (39-41). This need for minimally invasive tests could be achieved by targeting surrogate 
tissues, since it is now well recognised that AD is not a disorder restricted to pathology and 
biomarkers within the brain only. Combining neutral lipid accumulation, DNA content with other 
potential more specific protein markers may substantially increase the likelihood of better predictive 
markers for AD. Such a combined protocol would provide a high-content, automated assay capable 
of measuring multiple parameters in human buccal cells simultaneously. 
  François et al. 
Page | 20  
 
Acknowledgments 
The authors thank Maryam Hor for the processing of buccal cells. Financial support from the CSIRO’s 
Preventative Health Flagship is gratefully acknowledged. This project was part funded by a grant 
from The JO & JR Wicking Trust, which is managed by ANZ Trustees (Australia). The authors declare 
they have no Conflict of Interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  François et al. 
Page | 21  
 
 
Table and Figure Legends 
Table 1. ROC curves for individual and combination of biomarkers. 
ROC curve results obtained for LSC biomarkers and their combinations for data in all cell types 
comparing controls and MCI. Abbreviations; AUC, area under the curve; ORO, Oil Red O; %>2N, % of 
>2N nuclei; **, p<0.01; ***, p<0.001. 
Figure 1. Buccal cell types analysed by LSC. 
(A) Schematic showing an example of the different cell types present in a buccal sample and the 
various parameters that are measured by laser scanning cytometry. In the schematic (upper left 
panel of (A)), the various types of individual cells that are classified by LSC are shown (basal, 
differentiated, transitional and karyolytic). Additionally, a group of 6 cells is shown in the centre 
since it was not possible to allocate a cellular classification to cells when they appeared in groups. 
(Ai) When the integral fluorescence from all nuclei (blue circles) was examined, both DNA content 
and nuclear circularity was measured. Since cells that are grouped cannot be classified by LSC as 
basal, differentiated, transitional or karyolytic, a ratio of the total lipid area (red circles) and the total 
cytoplasm area (green) was applied to all cells on the microscope slides to obtain the 
lipidArea/cytoplasmArea ratio. (Aii) When isolated single cells (i.e. cells that do not exist in a group of 
cells) were classified, the following cell types were scored; basal, transitional, differentiated and 
karyolytic. Additionally, within each of those classified cells types the following parameters were 
measured; lipid content, DNA content and nuclear circularity. (B-E) LSC images of representative 
different buccal cell types. (B) basal, (C) transitional, (D) differentiated and (E) karyolytic cells are 
shown. Note the green contour line indicating the cytoplasmic periphery of the cells, the blue 
contour lines around nuclei and the magenta contour lines around Oil Red O spots in the cytoplasm. 
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Figure 2. DNA content of nuclei measured by LSC in buccal cells from controls (n=26), MCI (n=13) 
and AD (n=13). DNA content of nuclei from (A) all buccal cell types including cells in groups, (B) single 
mononucleated cells (C) basal cells, (D) transitional cells and (E) differentiated cells. Abbreviations; 
AD, Alzheimer’s disease; a.u. arbitrary units; MCI, Mild cognitively impaired; *p<0.05, **p<0.01, 
***p<0.001. 
Figure 3. Oil Red O Content in buccal cells measured by LSC. Cell types were compared in buccal cells 
from controls (n=26), MCI (n=13) and AD (n=13). Quantification of the accumulated ORO was 
calculated as described in methods. ORO staining (% of cytoplasm area) (A) for all cells, (B) for all 
single mononucleated cells, (C) basal cells, (D) transitional cells, (E) differentiated cells and (F) 
karyolytic cells. Abbreviations; AD, Alzheimer’s disease; MCI, Mild cognitively impaired; ORO, Oil red 
O; *p<0.05. 
Figure 4. DNA content/ORO ratio for buccal cells from controls (n=26), MCI (n=13) and AD (n=13). 
The DNA content/ORO ratios are shown (A) for all buccal cell types including those cells in groups, 
(B) all single mononucleated cells, (C) basal cells, (D) transitional cells and (E) differentiated cells. 
Abbreviations; AD, Alzheimer’s disease; a.u., arbitrary units; MCI, mild cognitively impaired; *p<0.05, 
**p<0.01, ***p<0.001. 
Figure 5. Ploidy measurement for nuclei in buccal cells by LSC. Comparison of DNA ploidy for 
Controls (n=26), MCI (n=13) and AD (n=13). Representative DNA histograms are shown for (A) 
controls, (B) MCI and (C) AD. DNA content data for all study participants are summarised as shown in 
(D), with the percentage of nuclei represented as <2N, 2N or >2N as described in methods. (E) The 
circularity parameter of LSC was applied demonstrating an increase in circularity (irregular shape) of 
nuclei in transitional cells observed in MCI and AD. Abbreviations; AD, Alzheimer’s disease; a.u., 
arbitrary units; MCI, mild cognitive impaired; *p<0.05, **, p<0.01; ***, p<0.001. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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